DSFCL
DCM Shriram Fine Chemicals financials
- Market cap
- ₹215 Cr
- Sector
- Chemicals
What DCM Shriram Fine Chemicals Limited does
DCM Shriram Fine Chemicals Limited manufactures and sells chemical intermediates used by pharmaceutical (API), agrochemical, optical-brightener, dye, perfumery and paint manufacturers in India and abroad. It also undertakes contract manufacturing of Statin intermediates for a leading multinational customer. The company runs two factories, Daurala Organics and Daurala Chemicals, at Daurala, Meerut, Uttar Pradesh. It was carved out of DCM Shriram Industries Limited's Chemical Undertaking via an NCLT-sanctioned demerger effective December 2025, with shares listed on BSE and NSE in February 2026.
Segments
- Fine chemical intermediates
- Contract manufacturing
- Manufacturing plants
- 2 (Daurala Organics & Daurala Chemicals, Daurala, Meerut, UP)
- End-industries served
- Pharmaceuticals (API), Agrochemicals, Optical Brighteners, Dyes, Perfumery, Paints
- Contract manufacturing line
- Statin intermediates for a global MNC customer
- Subsidiaries
- 1 (Daurala Foods & Beverages Pvt Ltd)
- Customer geography
- India and export markets
Quarterly results
Q1 FY27: revenue down 7.9%, net profit down 41.4% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 93 | 113 | 99 | 97 | 97 +4% | 93 −18% | 91 −8% |
| EBITDA | 5 | 8 | 7 | -1 | 0 −93% | -2 −132% | 5 −30% |
| Net profit | 2 | 4 | 4 | -3 | -2 −174% | -4 −196% | 2 −41% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −47.9% YTD
YTD: ₹47.5 on 17 Feb 2026 → ₹24.73. High ₹47.5 (17 Feb 2026), low ₹17.36 (30 Mar 2026).
Financials, as filed
| Year ending | FY26 |
|---|---|
| Revenue | ₹386 Cr |
| Operating profit | ₹4 Cr |
| Operating margin | 0.9% |
| Interest | ₹1 Cr |
| Depreciation | ₹9 Cr |
| Net profit | ₹-4 Cr |
| Net margin | -1.1% |
| Cash from operations | ₹16 Cr |
| Free cash flow | ₹36 Cr |
| ROCE | 0.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY25 | FY26 |
|---|---|---|
| Equity capital | ₹0 Cr | ₹17 Cr |
| Reserves | ₹205 Cr | ₹183 Cr |
| Borrowings | ₹13 Cr | ₹13 Cr |
| Other liabilities | ₹80 Cr | ₹72 Cr |
| Total liabilities | ₹298 Cr | ₹285 Cr |
| Fixed assets | ₹131 Cr | ₹103 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr |
| Investments | ₹27 Cr | ₹38 Cr |
| Other assets | ₹140 Cr | ₹143 Cr |
| Total assets | ₹298 Cr | ₹285 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Dec 2025, the public added +1.91 pp while DIIs trimmed −1.35 pp. The shareholder count shrank 4% to 42,493.
- Promoters
- 50.1%
- FIIs
- 1.0%
- DIIs
- 11.4%
- Public
- 37.5%
Since Dec 2025
- Public +1.91 pp
- DIIs −1.35 pp
- FIIs −0.46 pp
How it drifted, 3 quarters
Over this window the public went from 35.6% to 37.5% — +1.9 pp.
Ownership split by quarter, oldest first. Dec '25: Promoters 50.1%, FIIs 1.5%, DIIs 12.7%, Government 0.1%, Public 35.6%.Mar '26: Promoters 50.1%, FIIs 1.5%, DIIs 11.9%, Government 0.1%, Public 36.4%.Jun '26: Promoters 50.1%, FIIs 1.0%, DIIs 11.4%, Public 37.5%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- H B Portfolio Limited NBFC / DFI newly disclosed 3.74% held
The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of DCM Shriram Fine Chemicals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Lala Bansi Dhar & Sons | 13.83% | unchanged |
| Madhav Bansidhar Shriram | 10.28% | unchanged |
| Alok Bansidhar Shriram | 10.28% | unchanged |
| Urvashi Tilakdhar | 6.77% | unchanged |
| Life Insurance Corporation Of India Insurer | 4.64% | unchanged |
| H B Portfolio Limited NBFC / DFI | 3.74% | newly disclosed |
| Akshay Foundation | 3.42% | unchanged |
| Investor Education And Protection Fund Authority M | 3.39% | unchanged |
| Abakkus Emerging Opportunities Fund-1 AIF | 2.86% | unchanged |
| Suman Bansi Dhar | 2.02% | unchanged |
| Akshay Dhar | 1.76% | unchanged |
| Aditi Dhar | 1.76% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse DCM Shriram Fine Chemicals Limited
Guides on how to read this kind of business and the numbers that matter.